Chamath Palihapitiya created 4 new SPACs that started trading today. Each of the new SPACs will focus on a different area of biotech:
- Social Capital Suvretta Holdings Corp. I, DNAA, will focus on neurology
- Social Capital Suvretta Holdings Corp. II, DNAB, will target oncology
- Social Capital Suvretta Holdings Corp. III, DNAC, will begin with a focus on “the organ space subsector”
- Social Capital Suvretta Holdings Corp. IV, DNAD, will look for a merger in the immunology sector